-
公开(公告)号:US20050234055A1
公开(公告)日:2005-10-20
申请号:US11154591
申请日:2005-06-17
申请人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
发明人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
IPC分类号: A61K31/4155 , A61K31/416 , A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/538 , C07D231/12 , C07D231/14 , C07D401/12 , C07D403/12 , C07D409/04 , C07D409/12 , C07D409/14 , C07D413/02 , C07D417/02 , C07D417/04 , C07D417/12 , C07D417/14 , C07D521/00 , C07D43/02 , C07D49/02
CPC分类号: C07D231/12 , C07D231/14 , C07D233/56 , C07D249/08 , C07D401/12 , C07D403/12 , C07D409/04 , C07D409/12 , C07D409/14 , C07D417/04 , C07D417/12 , C07D417/14
摘要: Drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-dependent calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-dependent calcium channel inhibitors containing the above compounds as the active ingredient, (in the formula, each symbol has the following meaning: B: phenylene, a nitrogen-containing, divalent, saturated ring group, or a monocyclic, divalent heteroaromatic ring group which may be substituted with Alk, X: —NR1—CR2R3—, —CR2R3—NR1—, —NR1—SO2—, —SO2—NR1— or —CR4═CR5—, and A: benzene ring which may have one or more substituents; mono-, di- or tricyclic fused heteroaryl which may have one or more substituents; cycloalkyl which may have one or more substituents; a nitrogen-containing, saturated ring group which may have one or more substituents; lower alkenyl which may have one or more substituents; lower alkynyl which may have one or more substituents; or Alk which may have one or more substituents).
摘要翻译: 药物,特别是具有钙释放依赖性钙通道抑制作用的药物组合物,特别是含有上述化合物作为活性成分的钙释放依赖性钙通道抑制剂的下述通式(I)表示的吡唑衍生物, (在该式中,每个符号具有以下含义:B:亚苯基,含氮,二价饱和环基或可被Alk,X:-NR 1取代的单环,二价杂芳族环基团 其中R 1,R 2,R 3,R 3,R 3,R 3, -NR 2 - , - SO 2 - , - SO 2 - , - SO 2 - , - SO 2 - , - SO 2 - 可以具有一个或多个取代基的一个 - 二环或三环稠合杂芳基,其可以具有一个或多个 取代基;可具有一个或多个取代基的环烷基;可具有一个或多个取代基的含氮饱和环基团 ents 可以具有一个或多个取代基的低级烯基; 可以具有一个或多个取代基的低级炔基; 或Alk,其可以具有一个或多个取代基)。
-
公开(公告)号:US4230084A
公开(公告)日:1980-10-28
申请号:US28522
申请日:1979-04-09
申请人: Isamu Gotoh , Yoshinori Okamoto , Goroei Wakatsuki
发明人: Isamu Gotoh , Yoshinori Okamoto , Goroei Wakatsuki
CPC分类号: F02N5/02
摘要: An engine starting device for starting an engine by connecting an output member on the side of a spiral spring and an input member on the side of the engine with each other when the force accumulation by the spring is released. A driving member is driven by the output of the engine. An automatic force accumulating operation for the spiral spring is driven by the driving member. A one-way clutch mechanism connects the automatic force accumulating operation means in a winding pressure accumulating mechanism for the spiral spring with each other.
摘要翻译: 一种用于起动发动机的发动机启动装置,当弹簧的力积聚被释放时,通过将螺旋弹簧的一侧的输出构件和发动机侧的输入构件相互连接来起动发动机。 驱动构件由发动机的输出驱动。 用于螺旋弹簧的自动力积累操作由驱动构件驱动。 单向离合器机构将用于螺旋弹簧的卷绕压力积累机构中的自动力积存操作装置彼此连接。
-
公开(公告)号:US4037471A
公开(公告)日:1977-07-26
申请号:US691192
申请日:1976-05-28
申请人: Yoshinori Okamoto , Toshio Tsuruoka
发明人: Yoshinori Okamoto , Toshio Tsuruoka
CPC分类号: F01M11/065 , F01M11/12
摘要: An engine oil level detection device of a construction, wherein an observation window is provided in one part of an oil receptacle or pan, and a wiper to clean the inner surface of the window soiled with the lubricant oil stuck thereonto by splashing is held on the window portion in a manner to be rotatable by finger actions or by a tool.
摘要翻译: 一种结构的发动机油位检测装置,其中在油容器或盘的一部分中设置有观察窗,并且通过飞溅将粘附在其上的润滑油污染的窗户的内表面清洁的刮水器保持在 窗口部分以能够通过手指动作或工具旋转的方式。
-
公开(公告)号:US08524727B2
公开(公告)日:2013-09-03
申请号:US12933137
申请日:2010-03-29
申请人: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
发明人: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
IPC分类号: A01N43/54 , A61K31/505
CPC分类号: C07D239/42 , C07D239/34 , C07D239/38 , C07D239/48 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/06 , C07D451/04 , C07D453/02 , C07D491/107 , C07D493/08
摘要: A novel and excellent method for preventing and/or treating diseases related to a cannabinoid type 2 receptor, based on an agonistic action on a cannabinoid type 2 receptor. It was found that a hetero ring derivative mainly having two substituents, for example, a pyrimidine-5-carboxamide derivative having a substituent amino group at the 2-position, exhibits a potent agonistic action on a cannabinoid type 2 receptor, and can be an agent for preventing and/or treating diseases related to a cannabinoid type 2 receptor such as inflammatory diseases, pain, and the like.
摘要翻译: 基于对大麻素2型受体的激动作用,预防和/或治疗与大麻素2型受体相关的疾病的新颖且优异的方法。 发现主要具有两个取代基的杂环衍生物,例如2-位具有取代基氨基的嘧啶-5-甲酰胺衍生物对大麻素2型受体表现出强烈的激动作用,并且可以是 用于预防和/或治疗与大麻素2型受体相关的疾病如炎性疾病,疼痛等的药剂。
-
公开(公告)号:US20110053912A1
公开(公告)日:2011-03-03
申请号:US12933137
申请日:2010-03-29
申请人: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
发明人: Yuji Matsushima , Hirokazu Kubota , Hisao Hamaguchi , Yoshinori Okamoto , Takeshi Hondo , Fusako Nishigaki
IPC分类号: A61K31/55 , C07D405/12 , A61K31/506 , A61P29/00 , C07D413/12 , A61K31/5377 , C07D417/12 , A61K31/541 , C07D491/107 , C07D417/14
CPC分类号: C07D239/42 , C07D239/34 , C07D239/38 , C07D239/48 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D413/06 , C07D451/04 , C07D453/02 , C07D491/107 , C07D493/08
摘要: A novel and excellent method for preventing and/or treating diseases related to a cannabinoid type 2 receptor, based on an agonistic action on a cannabinoid type 2 receptor. It was found that a hetero ring derivative mainly having two substituents, for example, a pyrimidine-5-carboxamide derivative having a substituent amino group at the 2-position, exhibits a potent agonistic action on a cannabinoid type 2 receptor, and can be an agent for preventing and/or treating diseases related to a cannabinoid type 2 receptor such as inflammatory diseases, pain, and the like.
摘要翻译: 基于对大麻素2型受体的激动作用,预防和/或治疗与大麻素2型受体相关的疾病的新颖且优异的方法。 发现主要具有两个取代基的杂环衍生物,例如2-位具有取代基氨基的嘧啶-5-甲酰胺衍生物对大麻素2型受体表现出强烈的激动作用,并且可以是 用于预防和/或治疗与大麻素2型受体相关的疾病如炎性疾病,疼痛等的药剂。
-
公开(公告)号:US07247635B2
公开(公告)日:2007-07-24
申请号:US11154591
申请日:2005-06-17
申请人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
发明人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
IPC分类号: C07D231/12 , A61K31/415
CPC分类号: C07D231/12 , C07D231/14 , C07D233/56 , C07D249/08 , C07D401/12 , C07D403/12 , C07D409/04 , C07D409/12 , C07D409/14 , C07D417/04 , C07D417/12 , C07D417/14
摘要: Drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-dependent calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-dependent calcium channel inhibitors containing the above compounds as the active ingredient, (in the formula, each symbol has the following meaning: B: phenylene, a nitrogen-containing, divalent, saturated ring group, or a monocyclic, divalent heteroaromatic ring group which may be substituted with Alk, X: —NR1—CR2R3—, —CR2R3—NR1—, —NR1—SO2—, —SO2—NR1— or —CR4═CR5—, and A: benzene ring which may have one or more substituents; mono-, di- or tricyclic fused heteroaryl which may have one or more substituents; cycloalkyl which may have one or more substituents; a nitrogen-containing, saturated ring group which may have one or more substituents; lower alkenyl which may have one or more substituents; lower alkynyl which may have one or more substituents; or Alk which may have one or more substituents).
摘要翻译: 药物,特别是具有钙释放依赖性钙通道抑制作用的药物组合物,特别是含有上述化合物作为活性成分的钙释放依赖性钙通道抑制剂的下述通式(I)表示的吡唑衍生物, (在该式中,每个符号具有以下含义:B:亚苯基,含氮,二价饱和环基或可被Alk,X:-NR 1取代的单环,二价杂芳族环基团 其中R 1,R 2,R 3,R 3,R 3,R 3, -NR 2 - , - SO 2 - , - SO 2 - , - SO 2 - , - SO 2 - , - SO 2 - 可以具有一个或多个取代基的一个 - 二环或三环稠合杂芳基,其可以具有一个或多个 取代基;可具有一个或多个取代基的环烷基;可具有一个或多个取代基的含氮饱和环基团 ents 可以具有一个或多个取代基的低级烯基; 可以具有一个或多个取代基的低级炔基; 或Alk,其可以具有一个或多个取代基)。
-
公开(公告)号:US07173033B2
公开(公告)日:2007-02-06
申请号:US11190859
申请日:2005-07-28
申请人: Susumu Igarashi , Ryo Naito , Yoshinori Okamoto , Noriyuki Kawano , Issei Tsukamoto , Ippei Sato , Makoto Takeuchi , Hiroyuki Kanoh , Masato Kobori
发明人: Susumu Igarashi , Ryo Naito , Yoshinori Okamoto , Noriyuki Kawano , Issei Tsukamoto , Ippei Sato , Makoto Takeuchi , Hiroyuki Kanoh , Masato Kobori
IPC分类号: C07D487/04 , A61K31/5025 , A61P19/08
CPC分类号: C07D487/04
摘要: As a result of an effort made by us for the purpose of developing a therapeutic agent having a bone formation-stimulating effect by promoting the functions of osteoblasts, the present inventors discovered that a certain nitrogen-containing heterocyclic compound exhibits a potent bone formation-stimulating effect on the osteoblast and thus can serve as an excellent prophylactic or therapeutic agent against a metabolic bone disease, whereby establishing the present invention.Thus, the present invention provides a 3,6-disubstituted 1,2,4-triazolo[4,3-b]pyridazine compound or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition comprising such a compound and a pharmaceutically acceptable carrier, especially a bone-forming agent.
摘要翻译: 本发明人为了通过促进成骨细胞的功能开发具有促进骨形成刺激作用的治疗剂而作出努力的结果,发现某些含氮杂环化合物表现出强有力的骨形成刺激 对成骨细胞的作用,因此可以作为抗代谢性骨病的优异的预防或治疗剂,由此建立本发明。 因此,本发明提供了3,6-二取代的1,2,4-三唑并[4,3-b]哒嗪化合物或其药学上可接受的盐,以及包含这种化合物和药学上可接受的载体的药物组合物, 特别是骨形成剂。
-
公开(公告)号:US20060264430A1
公开(公告)日:2006-11-23
申请号:US11399379
申请日:2006-04-07
申请人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
发明人: Hirokazu Kubota , Yasuhiro Yonetoku , Keizo Sugasawa , Masashi Funatsu , Souichirou Kawazoe , Akira Toyoshima , Yoshinori Okamoto , Jun Ishikawa , Makoto Takeuchi
IPC分类号: A61K31/538 , A61K31/5377 , A61K31/496 , A61K31/454 , A61K31/416 , C07D413/02 , C07D403/02
CPC分类号: C07D231/12 , C07D231/14 , C07D233/56 , C07D249/08 , C07D401/12 , C07D403/12 , C07D409/04 , C07D409/12 , C07D409/14 , C07D417/04 , C07D417/12 , C07D417/14
摘要: Drugs, in particular, pyrazole derivatives represented by the following general formula (I) which have a calcium release-activated calcium channel inhibitory effect and medicinal compositions, in particular, calcium release-activated calcium channel inhibitors containing the above compounds as the active ingredient, (in the formula, each symbol has the following meaning: D: pyrazolyl which may have 1 to 3 substituents selected from the group consisting of -Alk, -lower alkenyl, -lower alkynyl, -halogeno-lower alkyl, -Alk-cycloalkyl, -Alk-O-Alk, -cycloalkyl, —O-Alk, —COOH, —COO-Alk and -Hal, n: 0 or 1, B: phenylene, a nitrogen-containing, divalent, saturated ring group, or a monocyclic, divalent heteroaromatic ring group which may be substituted with Alk, X: —NR1—CR2R3—, —CR2R3—NR1—, —NR1—SO2—, —SO2—NR1— or —CR4═CR5—, and A: benzene ring which may have one or more substituents; mono-, di- or tricyclic fused heteroaryl which may have one or more substituents; cycloalkyl which may have one or more substituents; a nitrogen-containing, saturated ring group which may have one or more substituents; lower alkenyl which may have one or more substituents; lower alkynyl which may have one or more substituents; or Alk which may have one or more substituents).
摘要翻译: 药物,特别是具有钙释放激活的钙通道抑制作用的以下通式(I)表示的吡唑衍生物和药物组合物,特别是含有上述化合物作为活性成分的钙释放激活的钙通道抑制剂, (式中,每个符号具有以下含义:D:吡唑基,其可以具有1〜3个选自-Alk, - 低级烯基, - 低级炔基, - 卤代 - 低级烷基,-Al-环烷基, -Alk-O-Alk, - 环烷基,-O-Alk,-COOH,-COO-Alk和-Hal,n:0或1,B:亚苯基,含氮二价饱和环基或单环 可以被Alk取代的二价杂芳族环基团,X:-NR 1 -CR 2,R 3,..., 2,-NR 3 -NR 1 - , - NR 1 -SO 2 - , - SO 2 - , - SO 2 或者-CR 4 -CR 5 - ,以及可以具有的A:苯环 一个o 更多取代基; 可以具有一个或多个取代基的单 - ,二 - 或三环稠合杂芳基; 可以具有一个或多个取代基的环烷基; 可具有一个或多个取代基的含氮饱和环基; 可以具有一个或多个取代基的低级烯基; 可以具有一个或多个取代基的低级炔基; 或Alk,其可以具有一个或多个取代基)。
-
公开(公告)号:US20050261297A1
公开(公告)日:2005-11-24
申请号:US11190859
申请日:2005-07-28
申请人: Susumu Igarashi , Ryo Naito , Yoshinori Okamoto , Noriyuki Kawano , Issei Tsukamoto , Ippei Sato , Makoto Takeuchi , Hiroyuki Kanoh , Masato Kobori
发明人: Susumu Igarashi , Ryo Naito , Yoshinori Okamoto , Noriyuki Kawano , Issei Tsukamoto , Ippei Sato , Makoto Takeuchi , Hiroyuki Kanoh , Masato Kobori
IPC分类号: A61P19/00 , A61P19/08 , A61P19/10 , A61P43/00 , C07D487/04 , A61K31/503 , A61K31/55
CPC分类号: C07D487/04
摘要: As a result of an effort made by us for the purpose of developing a therapeutic agent having a bone formation-stimulating effect by promoting the functions of osteoblasts, the present inventors discovered that a certain nitrogen-containing heterocyclic compound exhibits a potent bone formation-stimulating effect on the osteoblast and thus can serve as an excellent prophylactic or therapeutic agent against a metabolic bone disease, whereby establishing the present invention. Thus, the present invention provides a 3,6-disubstituted 1,2,4-triazolo[4,3-b]pyridazine compound or a pharmaceutically acceptable salt thereof as well as a pharmaceutical composition comprising such a compound and a pharmaceutically acceptable carrier, especially a bone-forming agent.
-
公开(公告)号:US6017927A
公开(公告)日:2000-01-25
申请号:US860377
申请日:1997-08-28
申请人: Makoto Takeuchi , Ryo Naito , Masahiko Hayakawa , Yoshinori Okamoto , Yasuhiro Yonetoku , Ken Ikeda , Yasuo Isomura
发明人: Makoto Takeuchi , Ryo Naito , Masahiko Hayakawa , Yoshinori Okamoto , Yasuhiro Yonetoku , Ken Ikeda , Yasuo Isomura
IPC分类号: A61K31/439 , A61P1/00 , A61P11/00 , A61P11/06 , A61P13/00 , A61P13/10 , A61P29/00 , A61P31/00 , A61P43/00 , C07D221/12 , C07D453/02 , C07D471/04 , C09K19/34 , C09K19/40 , A61K31/435
CPC分类号: C07D221/12 , C07D453/02 , C09K19/3444
摘要: Quinuclidine derivatives represented by general following general formula (I), salts, N-oxides or quaternary ammonium salts thereof, and medicinal compositions containing the same. ##STR1## The compound has an antagonistic effect on muscarinic M.sub.3 receptors and is useful as a preventive or remedy for urologic diseases, respiratory diseases or digestive diseases.
摘要翻译: PCT No.PCT / JP95 / 02713 Sec。 371日期1997年8月28日 102(e)日期1997年8月28日PCT 1995年12月27日PCT PCT。 公开号WO96 / 20194 日本时间1997年7月4日由以下通式(I)表示的奎宁环衍生物,其盐,N-氧化物或季铵盐,以及含有它们的药物组合物。 该化合物对毒蕈碱M3受体具有拮抗作用,可用作泌尿系统疾病,呼吸系统疾病或消化系统疾病的预防或治疗。
-
-
-
-
-
-
-
-
-